Or­chard se­cures re­im­burse­ment for gene ther­a­py; UK fines drug­mak­ers $47M for an­ti­com­pet­i­tive scheme

Or­chard Ther­a­peu­tics an­nounced this week that the com­pa­ny has agreed to a re­im­burse­ment deal with Eng­land’s NHS for cov­er­age of its gene ther­a­py Lib­meldy. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER